Cat. No.: X24-08-YM344
Gap junction protein inhibitor, GnRH associated peptide (GAP) (1-13), human, Purity ≥98%
Synonym: 100111-07-7; GAP (1-13), human; (4S)-5-[[(2S)-4-Amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-4-carboxy-1-[[(2S,3S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]propanoyl]amino]-5-oxopentanoic acid
- CAS Number: 100111-07-7
- Compound CID: 16131399
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Properties
Description
GnRH associated peptide (GAP) (1-13), human is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting gap junction protein.
Molecular Formula
C65H101N15O25
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
GnRH associated peptide (GAP) (1-13), human is a cytoskeletal signaling inhibitor that can be used for its role in reproductive physiology.
Related Products
-
Gap junction protein inhibitor, Tonabersat, Purity ≥98%
-
Gap junction protein inhibitor, Gap 26, Purity ≥98%
-
Gap junction protein inhibitor, Gap 27, Purity ≥98%
-
Gap junction protein inhibitor, 10Panx, Purity ≥98%
-
Gap junction protein inhibitor, Scrambled 10Panx, Purity ≥98%
-
Gap junction protein inhibitor, GAP-134, Purity ≥98%
